학술논문
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Document Type
Article
Author
Lockman, S.; Sax, P.E.; Moyo, S.; Masheto, G.; Shapiro, R.L.; Brummel, S.S.; Ziemba, L.; Stranix-Chibanda, L.; McCarthy, K.; Coletti, A.; Jean-Philippe, P.; Purdue, L.; Chakhtoura, N.; Johnston, B.; Krotje, C.; Fairlie, L.; Cassim, H.; Hoffman, R.M.; Currier, J.; Stringer, J.S.; Chinula, L.; Korutaro, V.; Mmbaga, B.T.; João, E.; Hanley, S.; Holmes, L.B.; Momper, J.D.; Thoofer, N.K.; Rooney, J.F.; Frenkel, L.M.; Amico, K.R.; Best, B.M.; Blanchette, C.; Browning, R.; Cheng, Y.; Fox, A.; Jaliaah, N.; Knowles, K.; Mirochnick, M.; Murtaugh, W.A.; Patras, E.; Pinilla, M.; van Wyk, J.; Whalen, F.
Source
In: The Lancet . (The Lancet, 3 April 2021, 397(10281):1276-1292)
Subject
Language
English
ISSN
1474547X
01406736
01406736